Which fusion inhibitor is approved for use in HIV?
Which one of the following drugs may be used for prevention of relapse of P. vivax infection?
Which of the following penicillins is effective against Pseudomonas?
Which of the following drugs is NOT a cell wall synthesis inhibitor?
What is the drug of choice for malaria during pregnancy?
In the treatment of Hepatitis C, interferon is combined with which drug?
Penicillin is effective against which of the following organisms?
Tetracycline is a broad-spectrum antibiotic. What is the primary mechanism of resistance developed against this drug?
Which anti-tuberculosis drug is not toxic to the liver?
Beta-lactamase production is a common mechanism of resistance in strains of H. influenzae, M. catarrhalis, and Neisseria gonorrhoeae. Which one of the following drugs is most likely to be effective against all strains of these organisms?
Explanation: **Explanation:** The correct answer is **Enfuvirtide**. **1. Why Enfuvirtide is correct:** HIV entry into a host cell involves three stages: attachment, co-receptor binding, and fusion. **Enfuvirtide** is a synthetic peptide that acts as a **fusion inhibitor**. It binds to the **gp41** subunit of the viral envelope glycoprotein, preventing the conformational changes required for the viral envelope to fuse with the host CD4 cell membrane. Because it is a peptide, it must be administered via **subcutaneous injection**. **2. Why the other options are incorrect:** * **Efavirenz (Option B):** This is a Non-Nucleoside Reverse Transcriptase Inhibitor (**NNRTI**). It inhibits the HIV-1 reverse transcriptase enzyme by binding to an allosteric site, preventing the synthesis of viral DNA. * **Emtricitabine (Option C):** This is a Nucleoside Reverse Transcriptase Inhibitor (**NRTI**). It acts as a chain terminator during the synthesis of viral DNA by competing with natural nucleotides. * **Atazanavir (Option D):** This is a **Protease Inhibitor (PI)**. It prevents the cleavage of Gag-Pol polyproteins, resulting in the production of immature, non-infectious virions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Maraviroc** is another entry inhibitor, but it is a **CCR5 antagonist** (prevents co-receptor binding), not a fusion inhibitor. * **Enfuvirtide Side Effects:** The most common side effect is **injection site reactions** (nodules, erythema). * **Mechanism Mnemonic:** Remember **gp41** for **F**usion (En**f**uvirtide) and **gp120** for **A**ttachment. * Enfuvirtide is typically reserved for "salvage therapy" in patients with multi-drug resistant HIV.
Explanation: **Explanation:** The correct answer is **Primaquine**. **1. Why Primaquine is correct:** *Plasmodium vivax* and *P. ovale* have a unique life cycle stage called the **hypnozoite** (latent form) that remains dormant in the liver. These hypnozoites can "wake up" months or years later, causing a clinical **relapse**. Primaquine is a tissue schizonticide and is the only widely used drug effective against these hepatic hypnozoites. This process of clearing the liver stage to prevent relapse is known as **Radical Cure**. **2. Why the other options are incorrect:** * **Chloroquine:** It is a potent blood schizonticide. While it is the drug of choice for treating the erythrocytic (symptomatic) stage of sensitive *P. vivax*, it has no effect on the liver hypnozoites and therefore cannot prevent relapse. * **Atovaquone:** Primarily used in combination with Proguanil (Malarone) for prophylaxis and treatment of chloroquine-resistant *P. falciparum*. It acts on the mitochondrial electron transport chain but is not used for the radical cure of *P. vivax*. * **Tetracycline:** Acts as a slow-acting blood schizonticide by inhibiting protein synthesis. It is used as an adjunct to quinine in resistant *P. falciparum* cases, not for preventing relapses. **High-Yield Clinical Pearls for NEET-PG:** * **G6PD Deficiency:** Before prescribing Primaquine, patients **must** be screened for G6PD deficiency, as the drug can cause severe **acute hemolytic anemia** in these individuals. * **Pregnancy:** Primaquine is **contraindicated** in pregnancy because the fetus is relatively G6PD deficient. * **Tafenoquine:** A newer long-acting analog of Primaquine that can be used as a single dose for radical cure. * **Recrudescence vs. Relapse:** Relapse (Vivax/Ovale) is due to hypnozoites; Recrudescence (Falciparum/Malariae) is due to the survival of erythrocytic forms due to inadequate treatment.
Explanation: **Explanation:** **1. Why Piperacillin is Correct:** Piperacillin belongs to the **Extended-spectrum penicillins** (specifically the Ureidopenicillins). These agents are specifically designed to penetrate the outer membrane of Gram-negative bacteria, including *Pseudomonas aeruginosa*. It inhibits cell wall synthesis by binding to penicillin-binding proteins (PBPs). In clinical practice, it is almost always combined with the beta-lactamase inhibitor **Tazobactam** (Zosyn) to broaden its coverage against resistant strains. **2. Why the Other Options are Incorrect:** * **Amoxicillin & Ampicillin:** These are **Aminopenicillins**. While they have better Gram-negative coverage than Penicillin G (e.g., *E. coli, H. influenzae*), they are completely ineffective against *Pseudomonas* because they cannot penetrate its complex outer membrane and are easily degraded by its beta-lactamases. * **Oxacillin:** This is an **Antistaphylococcal penicillin** (along with Nafcillin and Methicillin). Its narrow spectrum is specifically targeted toward *Staphylococcus aureus* (MSSA). It has no significant activity against Gram-negative organisms like *Pseudomonas*. **3. High-Yield Clinical Pearls for NEET-PG:** * **Anti-Pseudomonal Penicillins:** Remember them using the mnemonic **"TCP"**: **T**icarcillin (Carboxypenicillin), **C**arbenicillin, and **P**iperacillin (Ureidopenicillin). * **Potency:** Piperacillin is the most potent anti-pseudomonal penicillin. * **Other Anti-Pseudomonal Drugs:** * **Cephalosporins:** Ceftazidime (3rd gen) and Cefepime (4th gen). * **Carbapenems:** Imipenem, Meropenem, and Doripenem (**Note:** Ertapenem does *not* cover Pseudomonas). * **Monobactams:** Aztreonam. * **Fluoroquinolones:** Ciprofloxacin and Levofloxacin. * **Aminoglycosides:** Amikacin, Gentamicin, and Tobramycin.
Explanation: The correct answer is **Colistin**. To answer this question correctly, one must distinguish between drugs that inhibit the **synthesis** of the cell wall and those that disrupt the **integrity** of the cell membrane. **1. Why Colistin is the correct answer:** Colistin (Polymyxin E) is a **cell membrane disruptor**, not a cell wall synthesis inhibitor. It acts like a cationic detergent. It binds to lipopolysaccharides (LPS) and phospholipids in the outer membrane of Gram-negative bacteria, displacing calcium and magnesium ions. This leads to increased permeability, leakage of intracellular contents, and rapid cell death. [1] **2. Why the other options are incorrect:** All other options inhibit specific steps in the complex process of peptidoglycan (cell wall) synthesis: * **Fosfomycin:** Inhibits the enzyme **Enolpyruvate transferase (MurA)**, blocking the conversion of NAG to NAM. This is the earliest step in cell wall synthesis (cytoplasmic phase). * **Cycloserine:** A structural analog of D-alanine, it inhibits **L-alanine racemase** and **D-alanyl-D-alanine synthetase**, preventing the formation of the D-Ala-D-Ala dipeptide. [3] * **Bacitracin:** Inhibits the **dephosphorylation of C55-isoprenyl pyrophosphate** (bactoprenol), the lipid carrier that transports peptidoglycan subunits across the cell membrane. [2, 3] **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cell Wall Inhibitors:** "**P**enicillins **C**an **B**lock **F**ormation" (**P**enicillins/Cephalosporins, **C**ycloserine, **B**acitracin, **F**osfomycin) + Vancomycin. * **Colistin Toxicity:** It is highly nephrotoxic and neurotoxic; it is often used as a "last-resort" drug for Multi-Drug Resistant (MDR) Gram-negative infections like *Pseudomonas* and *Acinetobacter*. * **Fosfomycin** is a first-line drug for uncomplicated UTIs due to its high concentration in urine.
Explanation: **Explanation:** The management of malaria in pregnancy requires a balance between therapeutic efficacy and fetal safety. **Chloroquine** is the drug of choice for the treatment of uncomplicated malaria (specifically *P. vivax* and sensitive *P. falciparum*) during all trimesters of pregnancy. It is considered safe, non-teratogenic, and has a well-established safety profile for both the mother and the fetus. **Analysis of Options:** * **Chloroquine (Correct):** It is the gold standard for sensitive strains in pregnancy. For chloroquine-resistant *P. falciparum*, ACT (Artemisinin-based Combination Therapy) is now recommended by the WHO across all trimesters, but Chloroquine remains the classic answer for general sensitivity. * **Quinine:** Historically used for severe malaria or resistant cases in the first trimester. However, it is associated with severe hypoglycemia and is no longer the first-line choice if safer alternatives are available. * **Primaquine (Contraindicated):** This is the most important "wrong" option to remember. Primaquine causes **hemolysis in the fetus** (due to potential G6PD deficiency) and can lead to intrauterine death. It is strictly contraindicated throughout pregnancy. * **Mepacrine:** An older antimalarial rarely used today due to significant toxicity (psychosis, yellow skin discoloration) and is not a standard of care in pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Radical Cure:** Since Primaquine is contraindicated, radical cure for *P. vivax* (to kill hypnozoites) must be **deferred** until after delivery and after checking the infant's G6PD status if breastfeeding. * **Severe Malaria in Pregnancy:** IV Artesunate is the drug of choice for severe malaria in all trimesters. * **Chemoprophylaxis:** For pregnant travelers to endemic areas, Chloroquine is used where sensitive; Proguanil is an alternative.
Explanation: **Explanation:** **Why Ribavirin is Correct:** The traditional standard of care for chronic Hepatitis C (HCV) infection involves the combination of **Pegylated Interferon-alpha and Ribavirin**. Ribavirin is a guanosine analogue that exerts antiviral effects through multiple mechanisms, including inhibition of RNA-dependent RNA polymerase, induction of lethal mutagenesis (error catastrophe), and modulation of the host immune response. When used alone, Ribavirin is ineffective at clearing HCV; however, it acts **synergistically** with Interferon to significantly increase the Sustained Virological Response (SVR) rate and prevent relapses. **Why Other Options are Incorrect:** * **Acyclovir:** A guanosine analogue used primarily for Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). It requires viral thymidine kinase for activation, which HCV lacks. * **Lamivudine:** A nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV and **Hepatitis B (HBV)**, but it has no clinical efficacy against HCV. * **Indinavir:** A Protease Inhibitor used specifically in the HAART regimen for **HIV**. While newer HCV drugs (like Simeprevir) are also protease inhibitors, Indinavir does not target the HCV NS3/4A protease. **High-Yield Clinical Pearls for NEET-PG:** * **Ribavirin Toxicity:** The most characteristic side effect is **dose-dependent hemolytic anemia**. It is also highly **teratogenic** (contraindicated in pregnancy; effective contraception is required for 6 months post-treatment). * **Interferon Side Effects:** "Flu-like symptoms" (fever, chills, myalgia) and neuropsychiatric issues (severe depression/suicidal ideation). * **Current Trend:** While Interferon + Ribavirin was the gold standard, it has largely been replaced by **Direct-Acting Antivirals (DAAs)** like Sofosbuvir and Ledipasvir, which are interferon-free and have higher cure rates.
Explanation: Penicillin G (Benzylpenicillin) remains a cornerstone of antimicrobial therapy, primarily targeting Gram-positive cocci and specific Gram-negative organisms. Its mechanism involves inhibiting bacterial cell wall synthesis by binding to **Penicillin-Binding Proteins (PBPs)**, preventing the cross-linking of peptidoglycan [3]. **Why "All of the above" is correct:** * **Treponema pallidum (Option C):** Penicillin G is the **drug of choice** for all stages of Syphilis. *T. pallidum* has remarkably maintained its sensitivity to penicillin over decades, with no significant resistance reported. * **Neisseria meningitidis (Option A):** While Ceftriaxone is often used empirically for meningitis, Penicillin G remains highly effective against sensitive strains of *N. meningitidis* and is a preferred narrow-spectrum agent once sensitivity is confirmed [1]. * **Neisseria gonorrhoeae (Option B):** Historically, penicillin was the first-line treatment for Gonorrhea. Although high-level resistance (PPNG - Penicillinase-producing *N. gonorrhoeae*) has made it obsolete for empirical treatment in many regions, the organism is biologically susceptible to the drug's mechanism [1]. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice (DOC):** Benzathine Penicillin G is the DOC for **Syphilis** and **Rheumatic fever prophylaxis**. 2. **Jarisch-Herxheimer Reaction:** A classic side effect seen during the treatment of Syphilis with penicillin due to the release of endotoxins from dying spirochetes. 3. **Resistance:** Most *Staphylococci* are now resistant to Penicillin G due to **beta-lactamase (penicillinase)** production [2]. 4. **Excretion:** Penicillin is rapidly excreted by the kidneys via **tubular secretion** (90%); this process can be inhibited by **Probenecid** to prolong its action.
Explanation: ### Explanation **Correct Option: B. Efflux pump mechanism** Tetracyclines act by inhibiting protein synthesis through reversible binding to the **30S ribosomal subunit**. The most common and clinically significant mechanism of resistance is the **active efflux** of the drug out of the bacterial cell. This is mediated by plasmid-encoded transport proteins (e.g., **TetA**), which pump the drug out faster than it can diffuse in, preventing it from reaching inhibitory concentrations at the ribosome. Another important mechanism is **ribosomal protection**, where proteins (e.g., TetM) interfere with tetracycline binding. **Analysis of Incorrect Options:** * **A. Enzymatic inactivation:** While common for Penicillins (Beta-lactamases) and Aminoglycosides (acetyltransferases), it is a rare mechanism for tetracyclines (seen only in some *Bacteroides* species). * **C. Alteration of binding site:** This is the primary mechanism for **Macrolides** (methylation of 23S rRNA) and **Fluoroquinolones** (DNA gyrase mutations), but not the predominant mechanism for tetracyclines. * **D. Absence of metabolic pathway:** This refers to **intrinsic resistance** (e.g., anaerobic bacteria being resistant to aminoglycosides because they lack the oxygen-dependent transport required for drug entry). **NEET-PG High-Yield Pearls:** * **Tigecycline:** A glycylcycline developed specifically to overcome efflux-mediated resistance; it is effective against many tetracycline-resistant organisms (except *Proteus* and *Pseudomonas*). * **Drug of Choice (DOC):** Tetracyclines (specifically Doxycycline) remain the DOC for Rickettsial infections, Chlamydia, Cholera, and Brucellosis. * **Adverse Effects:** Look for "Fanconi Syndrome" (outdated/expired tetracyclines) and "Phototoxicity" (most common with Demeclocycline).
Explanation: **Explanation:** The correct answer is **Streptomycin** because it is an aminoglycoside, a class of drugs primarily excreted unchanged by the kidneys. Unlike most first-line anti-tuberculosis (ATT) drugs, streptomycin does not undergo hepatic metabolism and therefore lacks hepatotoxic potential. **Why the other options are incorrect:** * **Isoniazid (INH):** It is a major cause of drug-induced hepatitis. It is metabolized via acetylation; "slow acetylators" are at a higher risk of toxicity. It can also cause a transient rise in transaminases. * **Rifampicin:** It is hepatotoxic and typically causes a cholestatic pattern of jaundice. It is also a potent microsomal enzyme inducer, which can increase the hepatotoxicity of isoniazid when used in combination. * **Pyrazinamide:** This is considered the **most hepatotoxic** drug among the first-line ATT agents. It can cause severe liver injury and is often the first drug to be discontinued if jaundice occurs. **NEET-PG High-Yield Pearls:** 1. **Hepatotoxicity Ranking:** Pyrazinamide > Isoniazid > Rifampicin. Ethambutol and Streptomycin are the two first-line drugs that are **not** hepatotoxic. 2. **Streptomycin Toxicity:** Its primary dose-limiting toxicities are **ototoxicity** (vestibular > auditory) and **nephrotoxicity**. It is also contraindicated in pregnancy due to the risk of fetal eighth cranial nerve damage. 3. **Visual Side Effects:** If a question asks about visual disturbances (optic neuritis) instead of liver toxicity, the answer is **Ethambutol**. 4. **Management:** In patients with pre-existing liver disease, a "liver-friendly" regimen often includes Streptomycin and Ethambutol.
Explanation: **Explanation:** The core concept tested here is the stability of cephalosporins against beta-lactamases produced by common Gram-negative respiratory and sexually transmitted pathogens. **1. Why Ceftriaxone is Correct:** Ceftriaxone is a **third-generation cephalosporin**. Unlike earlier penicillins, third-generation cephalosporins are highly resistant to the beta-lactamases (penicillinases) produced by *H. influenzae*, *M. catarrhalis*, and *N. gonorrhoeae*. It possesses high potency and excellent tissue penetration, making it the drug of choice for empirical treatment of meningitis and gonococcal infections, regardless of beta-lactamase production. **2. Why Other Options are Incorrect:** * **Amoxicillin:** This is a penicillinase-susceptible penicillin. Strains of these organisms that produce beta-lactamase will readily hydrolyze the beta-lactam ring of amoxicillin, rendering it ineffective. (It would only work if combined with a suicide inhibitor like Clavulanic acid). * **Clindamycin:** This is a lincosamide that primarily targets Gram-positive cocci and anaerobes. It has **no significant activity** against aerobic Gram-negative rods like *H. influenzae* or *Neisseria* species. * **TMP-SMX (Co-trimoxazole):** While historically used, there is widespread resistance among *H. influenzae* and *N. gonorrhoeae* due to altered dihydropteroate synthase or dihydrofolate reductase enzymes. It is not reliable against beta-lactamase-producing strains in a clinical setting. **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Gonorrhea:** Ceftriaxone (250mg or 500mg IM single dose) is the current CDC-recommended treatment. * **Resistance Mechanism:** The primary resistance in *N. gonorrhoeae* is via plasmid-mediated beta-lactamase (penicillinase) production. * **Spectrum:** Third-generation cephalosporins (Ceftriaxone, Cefotaxime, Ceftazidime) are characterized by increased Gram-negative activity and decreased Gram-positive activity compared to first-generation agents.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free